Ann Thorac Surg 2009;87:1311-1319. doi:10.1016/j.athoracsur.2008.09.076
© 2009 The Society of Thoracic Surgeons
Review
A Systematic Review of Biocompatible Cardiopulmonary Bypass Circuits and Clinical Outcome
Marco Ranucci, MDa,*,
Anna Balduini, AHAb,
Antonio Ditta, CCPa,
Alessandra Boncilli, CCPa,
Simonetta Brozzi, CCPa
a Department of Cardiothoracic-Vascular Anesthesia and Intensive Care, IRCCS Policlinico S. Donato, Milan, Italy
b Scientific Literature Data Center and Library, IRCCS Policlinico S. Donato, Milan, Italy
* Address correspondence to Dr Ranucci, Department of Anesthesia and Intensive Care, IRCCS Policlinico S. Donato, Via Morandi 30, San Donato Milanese, Milan, 20097, Italy (Email: cardioanestesia{at}virgilio.it).
This systematic review and meta-analysis explores the clinical efficacy of biocompatible surfaces for cardiopulmonary bypass in adults. Thirty-six randomized controlled trials were retrieved for a total of 4360 patients. Patients treated with biocompatible circuits had a lower rate of packed red cells transfusions and atrial fibrillation, and shorter durations of stay in the intensive care unit. When the analysis was limited to high-quality studies, only a reduction in atrial fibrillation rate and a shorter stay in the intensive care unit remained significantly associated with the use of biocompatible surfaces. Using biocompatible surfaces without other measures to contain blood activation results in a limited clinical benefit.
Copyright © 2009 by The Society of Thoracic Surgeons.